John G. Ullman & Associates’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-16,000
| Closed | -$1.15M | – | 133 |
|
|
2018
Q4 | $1.15M | Buy |
+16,000
| New | +$1.15M | 0.23% | 69 |
|
|
2018
Q1 | – | Sell |
-2,550
| Closed | -$216K | – | 117 |
|
|
2017
Q4 | $216K | Sell |
2,550
-300
| -11% | -$25.4K | 0.04% | 109 |
|
|
2017
Q3 | $247K | Sell |
2,850
-53,140
| -95% | -$4.61M | 0.05% | 101 |
|
|
2017
Q2 | $4.32M | Sell |
55,990
-610
| -1% | -$47.1K | 0.86% | 45 |
|
|
2017
Q1 | $3.93M | Sell |
56,600
-1,320
| -2% | -$91.5K | 0.81% | 43 |
|
|
2016
Q4 | $3.43M | Buy |
57,920
+1,200
| +2% | +$71K | 0.72% | 50 |
|
|
2016
Q3 | $3.76M | Sell |
56,720
-1,000
| -2% | -$66.3K | 0.77% | 48 |
|
|
2016
Q2 | $3.12M | Buy |
+57,720
| New | +$3.12M | 0.64% | 54 |
|
|
2014
Q4 | – | Sell |
-46,371
| Closed | -$2.41M | – | 155 |
|
|
2014
Q3 | $2.41M | Sell |
46,371
-1,275
| -3% | -$66.3K | 0.46% | 63 |
|
|
2014
Q2 | $2.45M | Buy |
+47,646
| New | +$2.45M | 0.45% | 61 |
|